CS logo
small CS logo
Praxis Fuer Internistische Haematologie / Onkologie

Troisdorf, Germany
Internist in Troisdorf, North Rhine-Westphalia
Schloßstraße 18, 53840 Troisdorf

About Praxis Fuer Internistische Haematologie / Onkologie


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
German High-Grade Non-Hodgkin's Lymphoma Study Group
2
iOMEDICO AG
2
Daiichi Sankyo, Inc.
1
Elevation Oncology
1
Heinrich-Heine University, Duesseldorf
1
Hoffmann-La Roche
1
III. Medizinische Klinik Mannheim
1
University Hospital, Basel, Switzerland
1
Total Rows: 8

Clinical Trials at Praxis Fuer Internistische Haematologie / Onkologie


During the past decade, Praxis Fuer Internistische Haematologie / Onkologie conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1111112200000011Started TrialsCompleted Trails20172018201920200123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
1997-07-01
Unknown status
1,000
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
2005-11-01
2018-02-01
Completed
700
Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
2003-07-01
2011-10-01
Completed
817
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer
2004-01-01
Unknown status
1,234
Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer
2017-08-15
2018-11-30
Terminated
22
Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)
2018-08-07
2036-12-01
Recruiting
1,500
Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy
2019-07-10
2021-07-01
Completed
154

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Praxis Fuer Internistische Haematologie / Onkologie" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials, followed by "iOMEDICO AG" with 2 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "Elevation Oncology" with 1 trials sponsored and "Heinrich-Heine University, Duesseldorf" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Praxis Fuer Internistische Haematologie / Onkologie" #1 collaborator was "Roche Pharma AG" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Austrian Breast Cancer Study Group" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGerman High-GradeNon-Hodgkin'sLymphoma StudyGroup: 2German High-GradeNon-Hodgkin'sLymphoma StudyGroup: 2iOMEDICO AG: 2iOMEDICO AG: 2Daiichi Sankyo, Inc.: 1Daiichi Sankyo, Inc.: 1Elevation Oncology: 1Elevation Oncology: 1Heinrich-HeineUniversity, Duesseldorf:1Heinrich-HeineUniversity, Duesseldorf:1Hoffmann-La Roche: 1Hoffmann-La Roche: 1III. Medizinische KlinikMannheim: 1III. Medizinische KlinikMannheim: 1University Hospital,Basel, Switzerland: 1University Hospital,Basel, Switzerland: 1

Created with Highcharts 11.1.0Top CollaboratorsRoche Pharma AG: 2Roche Pharma AG: 2AstraZeneca: 1AstraZeneca: 1Austrian Breast CancerStudy Group: 1Austrian Breast CancerStudy Group: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1ETOP IBCSG PartnersFoundation: 1ETOP IBCSG PartnersFoundation: 1German Breast Group: 1German Breast Group: 1German CLL Study Group: 1German CLL Study Group: 1NSABP Foundation Inc: 1NSABP Foundation Inc: 1Spanish Breast CancerResearch Group (SOLTI):1Spanish Breast CancerResearch Group (SOLTI):1

Clinical Trials Conditions at Praxis Fuer Internistische Haematologie / Onkologie


According to Clinical.Site data, the most researched conditions in "Praxis Fuer Internistische Haematologie / Onkologie" are "Leukemia" (2 trials), "Lymphoma" (2 trials), "Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC" (1 trials), "Advanced Solid Tumors or Hematologic Malignancies" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Praxis Fuer Internistische Haematologie / Onkologie" in a lesser frequency.

Clinical Trials Intervention Types at Praxis Fuer Internistische Haematologie / Onkologie


Most popular intervention types in "Praxis Fuer Internistische Haematologie / Onkologie" are "Drug" (7 trials), "Biological" (4 trials), "Radiation" (4 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (4 trials), "doxorubicin hydrochloride" (3 trials), "radiation therapy" (3 trials), "filgrastim" (2 trials) and "prednisone" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Praxis Fuer Internistische Haematologie / Onkologie


The vast majority of trials in "Praxis Fuer Internistische Haematologie / Onkologie" are 8 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Praxis Fuer Internistische Haematologie / Onkologie


Currently, there are NaN active trials in "Praxis Fuer Internistische Haematologie / Onkologie". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Praxis Fuer Internistische Haematologie / Onkologie, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Praxis Fuer Internistische Haematologie / Onkologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4Not Applicable: 2Not Applicable: 2Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 4Completed: 4Recruiting: 3Recruiting: 3Unknown status: 2Unknown status: 2Terminated: 1Terminated: 1

Departments of Praxis Fuer Internistische Haematologie / Onkologie


Praxis Fuer Internistische Haematologie / Onkologie has several departments that took part in Clinical trials: "Dres. Helmut Forstbauer, Carsten Ziske und Kollegen; Onkologische Schwerpunktpraxis" - 4 trials